BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Huntington's disease clinical trials and catalysts

Active industry-sponsored trials on ClinicalTrials.gov for Huntington disease: 20 (14 sponsors; 1 newly posted in the last 180 days, 1 stopped in the last 180 days; 1 new-entrant sponsors). Momentum score 10, rank 69 of 91 on the disease-area ranking. As of 2026-11-18.

Phase distribution: Early Phase 1 0, Phase 1 4, Phase 2 8, Phase 3 6, Phase 4 0, N/A 2.

Most active sponsors, by phase

SponsorActive trialsBy phaseNew (window)Upcoming readouts
Skyhawk Therapeutics, Inc.3P3 301
Novartis Pharmaceuticals NVS2P3 1, P2 100
Neurocrine Biosciences NBIX1P3 100
Prilenia new entrant1P3 110
Hoffmann-La Roche3P2 2, P1 101
UniQure Biopharma B.V. QURE2P2 200
Alnylam Pharmaceuticals ALNY1P1 100
AskBio France, SAS, a subsidiary of AskBio Inc.1P2 100
BioSensics1NA 100
ExoRNA Bioscience1P2 100
InSightec1NA 100
Luye Pharma Group Ltd.1P1 100
Sarepta Therapeutics, Inc. SRPT1P1 100
Vico Therapeutics B. V.1P2 100

New-entrant sponsors: Prilenia.

Recently stopped trials

Upcoming trial readouts (next 90 days)

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
No industry Phase 2/3 readouts in the next 90 days.

FDA decision events (last 12 months and upcoming)

DateEventStatusCompanyDrugSource
2027-05-01PDUFA date (company-disclosed)pendinguniQure N.V. QUREifezuntirgenePDUFA May 1, 2027 - uniQure N.V. (ifezuntirgene)

Readouts in the last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
None found.

Landscape counts: ClinicalTrials.gov, industry lead sponsors, active statuses, via the free hosted BioCatalystFeed MCP tool condition_landscape (query "Huntington disease"); readouts matched by condition text. Registry counts only; not a forecast.

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.